(Q67864038)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1794268%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

title

Efficacy of gliclazide in comparison with other sulphonylureas in the treatment of NIDDM (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1794268%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1 reference

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90010-B

27 November 2022

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90010-B

27 November 2022

author name string

A. D. Harrower

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1794268

27 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1794268

27 November 2022

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1794268%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

18 September 2019

https://api.elsevier.com/content/article/PII:016882279190010B?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90010-B

https://api.elsevier.com/content/article/PII:016882279190010B?httpAccept=text/plain

27 November 2022

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90010-B

Diabetes Research and Clinical Practice

27 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1794268%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

volume

14 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1794268%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

page(s)

S65-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1794268%20AND%20SRC:MED&resulttype=core&format=json

The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs

18 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90010-B

Home blood glucose monitoring in non-insulin-dependent diabetics: the effect of gliclazide on blood glucose and weight control, a multicentre trial

27 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90010-B

Comparison of diabetic control in type 2 (non-insulin dependent) diabetic patients treated with different sulphonylureas

27 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90010-B

Glibenclamide-associated hypoglycaemia: a report on 57 cases

27 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90010-B

Comparison of gliclazide and glibenclamide treatment in non-insulin-dependent diabetes

27 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90010-B

Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents

27 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90010-B

27 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1794268%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1 reference